Showing results (691-700 of 903) with videos related to
Sort By:
Pageof 91
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2012
Human CCR4+ CCR6+ Th17 cells suppress autologous CD8+ T cell responsesFei Zhao, Bastian Hoechst, Jaba Gamrekelashvili, et al.Hepatology (Baltimore, Md.)|May 21, 2013
Adjuvant gemcitabine therapy improves survival in a locally induced, R0-resectable model of metastatic intrahepatic cholangiocarcinomaEngin Gürlevik, Bettina Fleischmann-Mundt, Nina Armbrecht, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 8, 2011
Grading of hypervascular hepatocellular carcinoma using late phase of contrast enhanced sonography - a prospective studyBita Boozari, Bisharah Soudah, Kinan Rifai, et al.Plos One|August 1, 2015
Benefit of Treatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort StudyWolf Peter Hofmann, Stefan Mauss, Thomas Lutz, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2016
Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-term Follow-upWillem P Brouwer, Henry Lik-Yuen Chan, Maurizia R Brunetto, et al.Journal of Hepatology|July 2, 2011
Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group reportHenry Lik-Yuen Chan, Alex Thompson, Michelle Martinot-Peignoux, et al.Scientific Reports|November 23, 2024
Different dynamics of soluble inflammatory mediators after clearance of respiratory SARS-CoV-2 versus blood-borne hepatitis C virus infectionsAntonia Zeuzem, Saumya Dileep Kumar, Carlos Oltmanns, et al.Hepatology (Baltimore, Md.)|April 5, 2012
Vaniprevir with pegylated interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C: a randomized phase II studyMichael P Manns, Edward Gane, Maribel Rodriguez-Torres, et al.Journal of Hepatology|February 24, 2007
HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administrationJens Rosenau, Therese Kreutz, Matthias Kujawa, et al.Digestive Diseases and Sciences|April 7, 2007
Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cellsFrank Tacke, Erwin Gäbele, Frauke Bataille, et al.Pageof 91